4.8 Article

Dual imaging of pulmonary delivery and gene expression of dry powder inhalant by fluorescence and bioluminescence

期刊

JOURNAL OF CONTROLLED RELEASE
卷 134, 期 2, 页码 149-154

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2008.11.018

关键词

Gene delivery system; Indocyanine green; Supercritical carbon dioxide; Dry powder; Dual imaging system IVIS

向作者/读者索取更多资源

in gene therapy with an inhalant, therapeutic outcome depends on both the pulmonary delivery of the agent and the gene expression properties in the lung. The aim of the present study was to visualize and evaluate both the pulmonary delivery and the gene expression properties of a dry powder at once in mice. We used indocyanine green (ICC) as a fluorescent label, the plasmid DNA pCMV-Luc encoding the firefly luciferase as a reporter, chitosan as a non-viral vector and lactose as a carrier of the dry powder prepared by a supercritical carbon dioxide process. The pulmonary delivery of the dry powder and the gene expression in the lung were evaluated by detection of fluorescence of ICG and the detection of luciferase activity, respectively, by using a real-time in vivo imaging system (IVIS (R) imaging system, Xenogen Corporation). The fluorescence and bioluminescence were more specifically detected by measuring from the back of the mice. We succeeded in visualizing both the pulmonary delivery and the gene expression in the same mouse that correlated with each other. In conclusion, the dry powder containing both ICG and pCMV-Luc was useful as a dual imaging system to visualize pulmonary delivery and gene expression in mice. (C) 2008 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Pharmacology & Pharmacy

Next Challenge From the Variance in Individual Physiologically-Based Pharmacokinetic Model-Predicted to Observed Morphine Concentration in Critically Ill Neonates

Chie Emoto, David Hahn, Joshua C. Euteneuer, Tomoyuki Mizuno, Alexander A. Vinks, Tsuyoshi Fukuda

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Article Pharmacology & Pharmacy

Population pharmacokinetic modelling of busulfan and the influence of body composition in paediatric Fanconi anaemia patients

Matthijs W. van Hoogdalem, Chie Emoto, Tsuyoshi Fukuda, Tomoyuki Mizuno, Parinda A. Mehta, Alexander A. Vinks

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)

Review Pharmacology & Pharmacy

Clinical implementation of pharmacogenetics and model-informed precision dosing to improve patient care

Tomoyuki Mizuno, Min Dong, Zachary L. Taylor, Laura B. Ramsey, Alexander A. Vinks

Summary: Providing maximal therapeutic efficacy without toxicity is a universal goal of rational drug therapy. However, substantial between-patient variability in drug response often impedes such successful treatments and brings the necessity of tailoring drug dose to individual needs for more precise therapy. In many cases, the integration of patient characteristics, such as body size, genetic makeup, and environmental factors, is needed to find the optimal dose in clinical practice. The development and implementation of pharmacogenetics-guided and PK/PD model-informed decision support, including the use of electronic health records, have facilitated precision dosing and improved healthcare.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)

Article Pharmacology & Pharmacy

MTXPK.org: A Clinical Decision Support Tool Evaluating High-Dose Methotrexate Pharmacokinetics to Inform Post-Infusion Care and Use of Glucarpidase

Zachary L. Taylor, Tomoyuki Mizuno, Nieko C. Punt, Balaji Baskaran, Adriana Navarro Sainz, William Shuman, Nicholas Felicelli, Alexander A. Vinks, Jesper Heldrup, Laura B. Ramsey

CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)

Article Pharmacology & Pharmacy

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome

Tomoyuki Mizuno, Brooks T. McPhail, Suyog Kamatkar, Scott Wexelblatt, Laura Ward, Uwe Christians, Henry T. Akinbi, Alexander A. Vinks

Summary: An integrated pharmacokinetic and pharmacodynamic model for buprenorphine treatment in newborns with neonatal opioid withdrawal syndrome was developed successfully, which could optimize the dosing regimen in the treatment of this condition.

CLINICAL PHARMACOKINETICS (2021)

Review Biochemistry & Molecular Biology

Pharmacotherapy of neonatal opioid withdrawal syndrome: a review of pharmacokinetics and pharmacodynamics

Matthijs W. van Hoogdalem, Brooks T. McPhail, David Hahn, Scott L. Wexelblatt, Henry T. Akinbi, Alexander A. Vinks, Tomoyuki Mizuno

Summary: Neonatal opioid withdrawal syndrome (NOWS) often occurs in infants born to mothers who used opioids during pregnancy. The pharmacological treatments for NOWS exhibit substantial variability in pharmacokinetics (PK) and pharmacodynamics (PD), with current treatments largely relying on empirical treatment of patient symptoms. Further research on the PK/PD relationship of medications used in the treatment of NOWS is needed.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)

Article Pharmacology & Pharmacy

Polypod-like structured guanine-rich oligonucleotide aptamer as a selective and cytotoxic nanostructured DNA to cancer cells

Kohta Mohri, Emi Hayashi, Manato Nishino, Nao Matsushita, Sohei Tanishita, Makiya Nishikawa, Shinji Sakuma

Summary: In this study, Guanine-rich oligonucleotide (GRO) was developed as an effective anticancer agent with high selectivity and antiproliferative activity in cancer cells. By incorporating GRO29A into polypod-like structured DNA, the potency of the drug was increased, showing high cytotoxicity against nucleolin-positive cancer cells.

JOURNAL OF DRUG TARGETING (2021)

Article Biotechnology & Applied Microbiology

Development of p53 knockout U87MG cell line for unbiased drug delivery testing system using CRISPR-Cas9 and transcriptomic analysis

Andrew Tae-Jun Kwon, Kohta Mohri, Satoshi Takizawa, Takahiro Arakawa, Maiko Takahashi, Bogumil Kaczkowski, Masaaki Furuno, Harukazu Suzuki, Shunsuke Tagami, Hidefumi Mukai, Erik Arner

Summary: This study demonstrated the creation of multiple mutant variants of U87MG cells using gene editing techniques, showing that loss of p53 function led to major transcriptional differences in the cells. Transcriptome data was used to predict mutant clones with less divergent phenotypes, which served as the best candidates for drug delivery testing platforms. In vitro and in vivo experiments supported these predictions, ultimately leading to the successful selection of the best qualifying mutant clone.

JOURNAL OF BIOTECHNOLOGY (2021)

Article Gastroenterology & Hepatology

Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease

Ruben J. Colman, Ye Xiong, Tomoyuki Mizuno, Jeffrey S. Hyams, Joshua D. Noe, Brendan Boyle, Geert R. D'Haens, Johan van Limbergen, Kelly Chun, Jane Yang, Michael J. Rosen, Lee A. Denson, Alexander A. Vinks, Phillip Minar

Summary: This study evaluated the impact of ATI on infliximab clearance and loss of response, finding that even low levels of ATI can affect drug clearance. The data suggest that dose optimization for low-level ATI can improve infliximab clearance and prevent loss of response.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Article Pharmacology & Pharmacy

Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome

Matthijs W. van Hoogdalem, Trevor N. Johnson, Brooks T. McPhail, Suyog Kamatkar, Scott L. Wexelblatt, Laura P. Ward, Uwe Christians, Henry T. Akinbi, Alexander A. Vinks, Tomoyuki Mizuno

Summary: Neonatal opioid withdrawal syndrome is a public health concern in the US, with sublingual buprenorphine emerging as a treatment. However, precision dosing is needed due to variability in newborns' pharmacokinetics. PBPK modeling shows biliary clearance, sublingual absorption, and CYP3A4 abundance drive buprenorphine PK variability.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Pharmacology & Pharmacy

64Cu-labeling of small extracellular vesicle surfaces via a cross-bridged macrocyclic chelator for pharmacokinetic study by positron emission tomography imaging

Shota Warashina, Maki Zouda, Kohta Mohri, Yasuhiro Wada, Kazuya Maeda, Yasuyoshi Watanabe, Hidefumi Mukai

Summary: A method of labeling small extracellular vesicles (sEVs) with Cu-64 was developed and applied to pharmacokinetics study. The labeled sEVs rapidly disappeared from the systemic blood circulation and mainly accumulated in the liver and spleen, suggesting the involvement of macrophages.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)

Article Gastroenterology & Hepatology

Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance

Ruben J. Colman, Tomoyuki Mizuno, Keizo Fukushima, David B. Haslam, Jeffrey S. Hyams, Brendan Boyle, Joshua D. Noe, Geert R. D'Haens, Johan Van Limbergen, Kelly Chun, Jane Yang, Lee A. Denson, Nicholas J. Ollberding, Alexander A. Vinks, Phillip Minar

Summary: This study established a pediatric vedolizumab pharmacokinetic model to optimize dosing. By analyzing fecal microbiota, it was found that an early abundance of butyrate-producing bacteria was associated with patients' response to vedolizumab.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Pharmacology & Pharmacy

Lasso peptide microcin J25 variant containing RGD motif as a PET probe for integrin a v ß 3 in tumor imaging

Kohta Mohri, Kim Phuong Huynh Nhat, Maki Zouda, Shota Warashina, Yasuhiro Wada, Yasuyoshi Watanabe, Shunsuke Tagami, Hidefumi Mukai

Summary: In this study, we generated a PET probe based on MccJ25 analog with an RGD motif and investigated its utility for tumor imaging. The probe showed high accumulation in tumors with integrin alpha v beta 3 expression and low non-specific accumulation in other tissues. These results suggest that MccJ25 variants can be useful tools for cancer molecular imaging.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2023)

Meeting Abstract Pharmacology & Pharmacy

POPULATION PHARMACOKINETICS OF INTERFERON-GAMMA 1B IN PATIENTS WITH ADVANCED SOLID TUMORS TREATED IN COMBINATION WITH NIVOLUMAB.

T. Mizuno, J. Nieves, A. Grahn, R. Alpaugh, M. R. Zibelman, A. A. Vinks

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Meeting Abstract Pharmacology & Pharmacy

PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL-BASED APPROACH TO A NEONATAL PHARMACOKINETIC-PHARMACOGENETIC STUDY: DEVELOPMENTAL CHANGE IN OCT1 EXPRESSION AND GENETIC EFFECTS ON MORPHINE DISPOSITION.

T. Fukuda, D. Hahn, J. C. Euteneuer, T. Mizuno, A. A. Vinks, C. Emoto

CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)

Review Chemistry, Multidisciplinary

Polymer mechanochemistry in drug delivery: From controlled release to precise activation

Zhiyuan Shi, Yong Hu, Xin Li

Summary: Controlled drug delivery systems that can respond to mechanical force offer a unique solution for on-demand drug activation and release. Among various mechanical stimuli, ultrasound (US) has advantages in achieving spatiotemporally controlled drug release. Traditional US-triggered drug release relies on heat-induced phase transitions or chemical transformations, while the cutting-edge approach of Sonopharmacology leverages polymer mechanochemistry. The remaining challenges and potential future directions in this field are also discussed.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Co-delivery of drugs by adhesive transdermal patches equipped with dissolving microneedles for the treatment of rheumatoid arthritis

Lijie Zheng, Yuanzheng Chen, Xun Gu, Yingying Li, Hanqing Zhao, Wenjun Shao, Tao Ma, Chuanbin Wu, Qingqing Wang

Summary: In this study, a novel dosage form consisting of dissolving microneedles and an adhesive transdermal patch was developed for the treatment of rheumatoid arthritis. In vitro and in vivo experiments demonstrated that the combination of drugs delivered by this dosage form effectively reduced joint inflammation and damage.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mucoadhesive chitosan microcapsules for controlled gastrointestinal delivery and oral bioavailability enhancement of low molecular weight peptides

Kyungjik Yang, Hwa Seung Han, Seung Hwan An, Kyung Hoon Park, Keonwook Nam, Shinha Hwang, Yuyeon Lee, Sung Yeon Cho, Taehyung Kim, Deokyeong Choe, Sang Won Kim, Wonkyu Yu, Hyunah Lee, Jiyong Park, Sangguan You, Dong- Gyu Jo, Ki Young Choi, Young Hoon Roh, Jae Hyung Park

Summary: This study developed CP-loaded CS microcapsules to enhance the oral bioavailability of CP through controlled gastrointestinal delivery. The optimized microcapsules exhibited desirable physicochemical properties, showed anti-photoaging effects via antioxidant activity, and achieved controlled release in the gastrointestinal tract. This research provides a simple and economical approach for enhancing the oral bioavailability of CP for customized bioactive compound administration.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Pressure-sensitive multivesicular liposomes as a smart drug-delivery system for high-altitude pulmonary edema

Huiyang Li, Shuo Liu, Wenjin Dai, Bingmei Yao, Yong Zhou, Sujia Si, Hairong Yu, Riguang Zhao, Fang Jin, Liqun Jiang

Summary: Changes in bodily fluid pressures are crucial in diseases like high-altitude pulmonary edema (HAPE). Researchers have developed hydrostatic pressure-sensitive multivesicular liposomes (PSMVLs) that can release drugs in response to pressure changes, with potential applications in HAPE treatment. Animal experiments showed that this system provides better protection for lung tissues and respiratory function, reducing the occurrence of pulmonary edema.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Biofunctional coacervate-based artificial protocells with membrane-like and cytoplasm-like structures for the treatment of persistent hyperuricemia

Qian Hu, Hongbing Lan, Yinmei Tian, Xiaonan Li, Mengmeng Wang, Jiao Zhang, Yulin Yu, Wei Chen, Li Kong, Yuanyuan Guo, Zhiping Zhang

Summary: Coacervate droplets formed through liquid-liquid phase separation have potential as delivery vesicles for therapeutics. However, their lack of physiological stability and membranes are challenges. In this study, polylysine-polynucleotide complex coacervate droplets with favorable stability were formulated to concentrate molecules and nanoparticles. Phospholipid membranes were further coated on the droplets to create coacervate-based artificial protocells (ArtPC) with membrane-like structures. These biofunctional ArtPC effectively reduced blood uric acid levels and prevented renal injuries.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer

Xiaowei Wang, Hongwei Lu, Fang Luo, Dan Wang, Apeng Wang, Xuelei Wang, Wenkai Feng, Xiaobo Wang, Jiayi Su, Mingliang Liu, Guimin Xia

Summary: Four novel lipid-like GEM diesters were synthesized and encapsulated into liposomes to improve the antitumor efficacy of Gemcitabine. The liposomes loaded with dimyristoyl GEM (LipodmGEM) showed enhanced cellular uptake, improved inhibition of cell migration, and a greatly extended half-life compared to free Gemcitabine. LipodmGEM successfully enriched the drug in the tumor and exhibited excellent anticancer efficacy in vivo with negligible systemic toxicity.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Microenvironment responsive charge-switchable nanoparticles act on biofilm eradication and virulence inhibition for chronic lung infection treatment

Pengyu Li, Jieyi Pan, Yating Dong, Yingying Sun, Yalong Wang, Kang Liao, Yili Chen, Xin Deng, Shihui Yu, Haiyan Hu

Summary: Chronic pulmonary infection caused by Pseudomonas aeruginosa is a serious public health problem with high mortality rates. In this study, infection-microenvironment responsive nanoparticles were developed to eradicate biofilms and inhibit virulence. These nanoparticles showed promising results in treating chronic pulmonary infections.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Quantitative image analysis of intracellular protein translocation in 3-dimensional tissues for pharmacodynamic studies of immunogenic cell death

Yajing Sun, Ze Lu, John A. Taylor, Jessie L. S. Au

Summary: A recent development in cancer chemotherapy is the use of cytotoxics to induce tumor-specific immune response through immunogenic cell death (ICD). This study describes a method that utilizes immunostaining and machine-learning to identify cells with ecto-CRT in intact 3-dimensional tissues. The method was successfully applied to study drug-induced ICD in human bladder cancer.

JOURNAL OF CONTROLLED RELEASE (2024)

Review Chemistry, Multidisciplinary

Strategies for gaseous neuromodulator release in chemical neuroscience: Experimental approaches and translational validation

Rafat Ali, Shantanu Sen, Rohil Hameed, Aamir Nazir, Sandeep Verma

Summary: This review provides a focused overview of emerging strategies for delivering gasotransmitters in a controlled and sustained manner to reestablish neurophysiological homeostasis.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Multifunctional hydrogel for synergistic reoxygenation and chemo/ photothermal therapy in metastatic breast cancer recurrence and wound infection

Jing Chen, Xinyi Zhang, Jinshen Zhang, Zhaoxia Wang, Guilan Zhu, Ming Geng, Jinmiao Zhu, Yajun Chen, Wei Wang, Youcui Xu

Summary: In this study, a multifunctional responsive hydrogel system was developed for synergistic reoxygenation and chemo/photothermal therapy. The hydrogel system showed both therapeutic effects against metastatic breast cancer and wound infection, making it a promising strategy for treating and preventing tumor recurrence and associated wound infection.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

Mitochondria-targeted SkQ1 nanoparticles for dry eye disease: Inhibiting NLRP3 inflammasome activation by preventing mitochondrial DNA oxidation

Baoshan Huang, Na Zhang, Xinying Qiu, Rui Zeng, Shuimiao Wang, Mengxia Hua, Qing Li, Kaihui Nan, Sen Lin

Summary: This study revealed that robust ROS can oxidize mitochondrial DNA (ox-mtDNA) and cause its release into the cytosol, resulting in the activation of NLRP3 inflammasome. By using the mitochondria-targeted antioxidant SkQ1 and a novel mitochondria-targeted nanoparticle (SkQ1 NP), it was found that mitochondrial ROS scavenging could in situ inhibit DED-induced mtDNA oxidation and suppress NLRP3-mediated inflammation.

JOURNAL OF CONTROLLED RELEASE (2024)

Article Chemistry, Multidisciplinary

An injectable carrier for spatiotemporal and sequential release of therapeutic substances to treat myocardial infarction

Wenqi Liu, Cheng Hu, Linyu Long, Shuyi He, Wen Zhang, Zhicun Wang, Li Yang, Yunbing Wang

Summary: Myocardial infarction is the leading cause of cardiovascular mortality, and current treatment methods have limitations. This study developed a smart carrier that can release different therapeutic substances for different pathological processes, effectively improving cardiac function, promoting cardiac repair, and preventing ventricular remodeling.

JOURNAL OF CONTROLLED RELEASE (2024)